4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidine carboxylic acid ethylester impurity manufacturer and supplier
RXN CHEMICALS PVT LTD., situated at Navi Mumbai, India which is in the business of
manufacturing and supplying of Pharmaceutical Impurities, Drug
Impurity, Drug Metabolites, Reference Standard Compound, and APIs.
We have manufactured of 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidine
carboxylic acid ethylester Impurity. It is fully characterized using HPLC, LC-MS, 1H
NMR spectra and COA and is confirmed with
RT, RRT and RF.
We also perform custom synthesis and purification of 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidine
carboxylic acid ethylester impurity from mg to gm scale.
4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidine
carboxylic acid ethylester Impurity
We also perform custom synthesis and purification of impurity
from mg to gm scale, isolation of unknown impurity from drug product and APIs,
structure elucidation as requested by our clients.
From past 5 years we
have been supporting all Domestic markets for Impurities & API in USA,
Impurities & API in Canada and Impurities & API European countries. Rxn Chemicals can support for all
Impurities which are acceptable to all regulatory agencies in the world,
US-FDA, MHRA, MCC, WHO, Brazil, Japan.
Rxn Chemicals is
manufacturer and supplier of unknown Impurity of 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidine
carboxylic acid ethylester impurity which can be used for ANDA filing/DMF filing also
in genotoxic study and pharmacological studies
Please feel free to
keep in touch with us about any of your business related requirements /
inquiries. We would like to offer our service to your company. We
will contact you for further discussion at a time which is convenient to you.
We look forward to a
wonderful relationship together and success for all concerned.
12/04/2016
Comments
Post a Comment